Skip to main content
Premium Trial:

Request an Annual Quote

RNAi Shop Nucleonics Secures $2.7M Investment from Oxford Finance

NEW YORK, Oct. 15 (GenomeWeb News) - RNAi-technology company Nucleonics has secured a $2.7 million equipment-financing investment from Oxford Finance Corporation, the company said this week.

Oxford Finance joins nine other venture capital funds that have already committed $50.8 million to support the development of Nucleonics' initial eiRNA therapeutic candidates for hepatitis B and C.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.